Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
32 hedge funds and large institutions have $22.4M invested in Ocera Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 6 closing their positions.
180% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 5
6% less funds holding
Funds holding: 34 → 32 (-2)
27% less capital invested
Capital invested by funds: $30.7M → $22.4M (-$8.3M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$276K |
| 2 |
PVI
Pura Vida Investments
New York
|
+$163K |
| 3 |
Renaissance Technologies
New York
|
+$135K |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$127K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$95.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.97M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.51M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$405K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$273K |
| 5 |
Millennium Management
New York
|
-$68.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BIM
26
BlackRock Investment Management
Wilmington,
Delaware
| $8K | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $5K | -$2.3K | -600 | -31% |
|
28
First Manhattan
New York
| $3K | +$3.83K | +1,000 | New |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | -$20.6K | -5,375 | -94% |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $1K | -$23 | -6 | -2% |
|
31
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $7 | +$5.83K | +1,520 | +647% |
|
|
RCM
32
RA Capital Management
Boston,
Massachusetts
| – | -$1.97M | -417,476 | Closed |
|
|
SFM
33
Sphera Funds Management
Tel Aviv,
Israel
| – | -$1.51M | -321,254 | Closed |
|
|
34
Westfield Capital Management
Boston,
Massachusetts
| – | -$405K | -85,982 | Closed |
|
|
35
Fidelity Investments
Boston,
Massachusetts
| – | -$273K | -58,000 | Closed |
|
36
Northern Trust
Chicago,
Illinois
| – | -$51K | -10,833 | Closed |
|
37
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$33K | -7,000 | Closed |
|
38
Bank of America
Charlotte,
North Carolina
| – | +$502 | +131 | New |
|
OCRX Hedge Fund Activity: Q2 2015 in Review
32 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q2 2015, worth a combined $22.4M — down 27% from $30.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of OCRX and 4 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 14 added.
The largest buyer was Endurant Capital Management, adding an estimated $276K. The largest seller was RA Capital Management, exiting entirely with an estimated $1.97M sold.
- 32 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q2 2015, down from 34 in Q1 2015.
- Funds reported $22.4M of Ocera Therapeutics, Inc. stock for Q2 2015, down 27% quarter-over-quarter.
- 4 funds opened new Ocera Therapeutics, Inc. positions in Q2 2015 and 6 closed out, a net change of -2 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q2 2015 was Endurant Capital Management, an estimated $276K added.
- The largest Ocera Therapeutics, Inc. seller in Q2 2015 was RA Capital Management, an estimated $1.97M sold.
Based on aggregated 13F filings for Q2 2015.